Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 2;5(1):34–40. doi: 10.1002/jgh3.12443

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Comparison of HBsAg reduction between the two subgroups according to the baseline factors in the ETV‐TAF and ETV groups. The median HBsAg changes in the subgroups with (a) HBsAg <3.00 log IU/mL: (), ETV‐TAF: HBsAg < 3.00 log IU/mL; (), ETV: HBsAg < 3.00 log IU/mL, (b) HBsAg ≥3.00 log IU/mL: (), ETV‐TAF: HBsAg ≥ 3.00 log IU/mL; (), ETV: HBsAg ≥ 3.00 log IU/mL, (c) positive HBeAg: (), ETV‐TAF: HBeAg positive; (), ETV: HBeAg positive, (d) negative HBeAg: (), ETV‐TAF: HBeAg negative; (), ETV: HBeAg negative, (e) HBV genotype B: (), ETV‐TAF: genotype B; (), ETV: genotype B, and (f) HBV genotype C: (), ETV‐TAF: genotype C; (), ETV: genotype C. ETV, entecavir; HBeAg, hepatitis B envelope antigen; HBsAg, hepatitis B surface antigen; TAF, tenofovir alafenamide.

Inline graphic — Comparison of HBsAg reduction between the two subgroups according to the baseline factors in the ETV‐TAF and ETV groups. The median HBsAg changes in the subgroups with (a) HBsAg <3.00 log IU/mL: (), ETV‐TAF: HBsAg < 3.00 log IU/mL; (), ETV: HBsAg < 3.00 log IU/mL, (b) HBsAg ≥3.00 log IU/mL: (), ETV‐TAF: HBsAg ≥ 3.00 log IU/mL; (), ETV: HBsAg ≥ 3.00 log IU/mL, (c) positive HBeAg: (), ETV‐TAF: HBeAg positive; (), ETV: HBeAg positive, (d) negative HBeAg: (), ETV‐TAF: HBeAg negative; (), ETV: HBeAg negative, (e) HBV genotype B: (), ETV‐TAF: genotype B; (), ETV: genotype B, and (f) HBV genotype C: (), ETV‐TAF: genotype C; (), ETV: genotype C. ETV, entecavir; HBeAg, hepatitis B envelope antigen; HBsAg, hepatitis B surface antigen; TAF, tenofovir alafenamide.